PCVs are for children aged 5 or younger and adults aged 65 or older. PPSV23 is for children aged 2 to 18 who have certain medical conditions, as well as adults who've had PCV15 or a previous vaccine called PCV13. Although thepneumonia vaccinecan’t prevent all cases, it can lower ...
31 However, there are limitations in serotype coverage by PCV13 vaccine due to the evolution and emergence of new pneumococcal serotypes.32 Developing new formulation of PCV vaccines—such as the 20-valent PCV (PCV20) that contains the capsular polysaccharide conjugates of serotypes present in ...
A different version of the vaccine (PCV15 and/or PCV20) is recommended for adults and those with immunocompromising conditions who have not yet gotten a pneumococcal conjugate vaccine. Pneumococcal Polysaccharide Vaccine (PPSV23) This vaccine may be recommended for older children and adults who ...
The primary series of PCV15 or PCV20 versions consists of 3 doses routinely given at 2, 4, and 6 months of age. The doctor may administer the first dose as early as 6 weeks of age. CDC recommends a fourth dose at 12 through 15 months of age. 4. What is the PCV vaccine used ...
In this setting, the FDA has granted licensure to PCV20 for adults ≥18 years of age for the prevention of pneumonia and invasive disease caused by the 20 vaccine serotypes. The IPD indication was based on immunologic comparability to PCV13 for the 13 shared serotypes and to PPSV23 for ...